Food and Drug Administration

Center for Drug Evaluation and Research


Arthritis Advisory Committee

Silver Spring Holiday Inn, 8777 Georgia Avenue, Silver Spring, MD


Open Public Hearing

March 5, 2003


NDA: 20-905, ARAVA, (leflunomide), Aventis Pharmaceuticals Inc.




1. Sidney M. Wolfe, MD, Director, Public Citizen Health Research Group


2. Kevin Brennan, Senior Vice President, Health Policy, Arthritis Foundation


3. Amye Leong, Spokesperson: United Nations Endorsed Bone and Joint Decade